Journals / Anadolu Psikiyatri Dergisi / 2008 / Cilt: 9 - Sayı: 2

Interferon alpha induced mania in a patient with malign melanoma: Case report

İnterferon alfa kullanan malign melanomlu bir hastada ortaya çıkan mani: Olgu sunumu

Pages
111–115
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper was presented a case of IFN-α induced mania in a patient treated for malign melanoma and with the family history of bipolar disorder.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Interferon alpha is commonly used in the treatment of several diseases because of their stimulating effects on immune response, such as viral hepatitis, malign melanoma and multiple sclerosis.
📊
Key Findings & Data:It was reported that IFN-α induce neuropsychiatric side effects such as depression, anxiety, psychosis, mania, suicidal ideation, somnolence and delirium in addition to flue like symptoms including weakness, fever, headache and myalgia.
💡
Conclusion & Impact:In this paper was presented a case of IFN-α induced mania in a patient treated for malign melanoma and with the family history of bipolar disorder.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İlaç toksisitesi · Melanom · İnterferon-alfa

Abstract

Interferon alpha is commonly used in the treatment of several diseases because of their stimulating effects on immune response, such as viral hepatitis, malign melanoma and multiple sclerosis. It was reported that IFN-α induce neuropsychiatric side effects such as depression, anxiety, psychosis, mania, suicidal ideation, somnolence and delirium in addition to flue like symptoms including weakness, fever, headache and myalgia. In this paper was presented a case of IFN-α induced mania in a patient treated for malign melanoma and with the family history of bipolar disorder.

Özet

İnterferon alfa (IFN-α), immün sistem üzerindeki uyarıcı etkileri nedeniyle malign melanom, viral hepatitler ve multipl skleroz gibi bazı hastalıkların tedavisinde yaygın olarak kullanılmaktadır. IFN-α kullanımına bağlı olarak halsizlik, ateş, baş ağrısı ve kas ağrısı gibi grip benzeri belirtilerin yanı sıra, depresyon, anksiyete, psikoz, mani, intihar düşünceleri, somnolans ve deliryum gibi nöropsikiyatrik belirtiler de bildirilmektedir. Bu yazıda bipolar bozukluk için aile öyküsü bulunan, malign melanom nedeni ile IFN-α kullanımı sırasında mani gelişen bir olgu sunulmuştur.

🔖

Cite This Article

KAYA, N., ZEYTİNCİ, İ. E., ŞAHİNGÖZ, M. (2008). Interferon alpha induced mania in a patient with malign melanoma: Case report. Anadolu Psikiyatri Dergisi, Cilt: 9 - Sayı: 2, 111–115. https://ajindex.com/articles/356061

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Irvin W, Legallo RL, Stoler MH, Rice LW, Taylor PT, Andersen WA. Vulvar melanoma: a retrospective analysis and literature review. Gynecol Oncol 2001; 83:457-465
  2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistic 1998. CA Cancer J Clin 1998; 48:1-29
  3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistic 1996. CA Cancer J Clin 1997; 47:5-27
  4. Robinson WA, Mughal TI, Thomas MR, Johnson M, Spiegel RJ. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2. Immunobiology 1986; 172:275-282
  5. Regha S, Ring S, Bedikian A. Treatment of metastatic melanoma with combined cemotherapy containing cisplatin, vinblastine and dacarbazine (DTIC) and biothearapy using interleukin- 2 and interferon alpha. Ann Oncol 1996; 7:827-835
  6. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:201-217
  7. Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse effects of interferon- α: recognition and management. CNS Drugs 2005; 19:105-123
  8. Greenberg DB, Jonasch E, Gadd MA, Ryan BF, Everett JR, et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes gabapentin may serve as a mood stabilizer. Cancer 2000; 89:356-362
  9. Uğuz Ş, Yurdagül E, Aydın H, Ünal M. Interferon kullanımına bağlı psikotik bozukluk: Olgu sunumu. Klinik Psikiyatri 2003; 6:170-173
  10. Valentine A, Meyers C, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of Interferon alpha therapy. Semin Oncol 1998; 25(Suppl.1):39-47
  11. Asnis GM, De La Garza R. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006; 40:322-335
  12. Lindsay KL, Davis GL, Schiff ER, Bodenheimer HC, Balart CA, Dienstaq JL, et al. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Hepatology 1996; 24:1034-1040
  13. Cotler SJ, Wartelle CF, Larson AM, Gretch DR, Jensen DM, Carithers RL. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepatitis 2000; 7: 211-217
  14. Feinstein A, O’Connor P, Feinstein K. Multiple sclerosis, interferon beta-1b and depression: a prospective investigation. J Neurol 2002; 249:815-820
  15. Patten SB, Metz LM. Interferon beta-1a and depression in relapsing–remit